What Is Griseofulvin? Uses, Dosage, and What You Need to Know in 2026

Griseofulvin is one of medicine's longest-serving antifungal drugs. Discovered in 1939 from a soil mold called Penicillium griseofulvum, it entered medical use in the late 1950s and has been treating ringworm infections ever since. It's on the World Health Organization's List of Essential Medicines — a recognition of its proven value, safety, and affordability in treating dermatophyte (ringworm) infections.

What Is Griseofulvin Used For?

Griseofulvin is specifically used to treat dermatophyte (ringworm) infections — fungal infections of the skin, hair, and nails caused by Trichophyton, Microsporum, or Epidermophyton species. It is taken by mouth (oral) and cannot be used topically. Its approved uses include:

Tinea capitis (scalp ringworm) — the most common indication, particularly in children. Griseofulvin is the drug of choice for this condition.

Tinea corporis (ringworm of the body) — circular, scaly patches on the skin

Tinea pedis (athlete's foot) — when topical treatments have failed

Tinea cruris (jock itch) — groin ringworm resistant to topical treatment

Tinea barbae (barber's itch) — fungal infection of the beard area

Onychomycosis (nail fungal infection) — though newer antifungals are often preferred due to shorter courses

Important: Griseofulvin does NOT treat bacterial infections, viral infections, Candida (yeast) infections, or non-dermatophyte fungal infections like those caused by Aspergillus, Candida, or Cryptococcus. It only works against dermatophytes.

What Are the Different Formulations of Griseofulvin?

Griseofulvin comes in two formulations:

Microsize (Grifulvin V): Available as 500 mg tablets and 125 mg/5 mL oral suspension. Absorption is variable (25–70%) and is best with a high-fat meal.

Ultramicrosize (Gris-PEG): Available as 125 mg and 250 mg tablets. Smaller particle size means nearly complete absorption — requires a lower dose to achieve the same effect as microsize.

What Is the Correct Dose of Griseofulvin?

Adults (microsize):

Tinea corporis, cruris, barbae: 500 mg/day for 2–4 weeks

Tinea pedis: 500 mg twice daily for 4–8 weeks

Onychomycosis (fingernails): 1,000 mg/day for 4–6 months

Onychomycosis (toenails): 1,000 mg/day for 6–18 months or longer

Children (microsize): 20–25 mg/kg/day for tinea capitis, typically for 6–12 weeks (increased from the historical 10–15 mg/kg/day due to concerns about rising resistance). Children weighing 14–23 kg: approximately 125–250 mg/day; over 23 kg: 250–500 mg/day.

Always follow your doctor's specific dosing instructions, as doses are individualized based on weight, formulation, and the type of infection being treated.

How Should You Take Griseofulvin?

Take it with a high-fat meal. Griseofulvin is not water-soluble, and fat dramatically improves its absorption. A meal containing whole milk, ice cream, peanut butter, eggs, or cheese works well. A low-fat diet significantly reduces how much of the drug your body absorbs.

Take the full course. Do not stop when symptoms improve. Stopping early allows the fungus to survive and cause relapse. Continue through the full prescribed course.

Avoid alcohol. Griseofulvin intensifies the effects of alcohol and can cause rapid heartbeat, flushing, and nausea.

Protect yourself from the sun. Griseofulvin causes photosensitivity. Use SPF 30+ sunscreen daily throughout treatment.

How Long Until You See Results?

Griseofulvin works slowly — it doesn't kill the existing fungus but prevents new fungal growth by binding to new keratin (the protein in skin, hair, and nails). Infected tissue must be replaced by new, uninfected tissue before you're cured. This is why treatment takes weeks to months:

Skin infections: Typically improve within 2–4 weeks; full course 4–8 weeks

Scalp infections (tinea capitis): Visible improvement in 4–6 weeks; full course 6–12 weeks

Nail infections (onychomycosis): Minimal visible change for months; fingernails 4–6 months; toenails 6–18 months

Who Should NOT Take Griseofulvin?

Griseofulvin is contraindicated (should not be used) in:

Pregnant women (especially the first trimester — teratogenic risk)

People with porphyria (a blood disorder)

People with liver failure or severe liver disease

Children under 2 years of age

People with known allergy to griseofulvin or penicillin (cross-reactivity is possible)

For a complete list of side effects and warnings, see our post on griseofulvin side effects.